Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Radiology. Artificial Intelligence|January 3, 2024
Performance of the Winning Algorithms of the RSNA 2022 Cervical Spine Fracture Detection ChallengeGhee Rye Lee, Adam E Flanders, Tyler Richards, et al.
Molecular Cancer Therapeutics|November 7, 2013
Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancerBrian Y Lee, Falko Hochgräfe, Hui-Ming Lin, et al.
Radiology. Artificial Intelligence|June 9, 2023
Augmentation of the RSNA Pulmonary Embolism CT Dataset with Bounding Box Annotations and Anatomic Localization of Pulmonary EmboliMatias F Callejas, Hui Ming Lin, Thomas Howard, et al.
Digestive Surgery|May 10, 2017
Risk Factors for Early Postoperative Small Bowel Obstruction after Elective Colon Cancer Surgery: An Observational Study of 1,244 Consecutive PatientsXiao-Jie Wang, Pan Chi, Hui-Ming Lin, et al.
NPJ Digital Medicine|May 7, 2025
High performance with fewer labels using semi-weakly supervised learning for pulmonary embolism diagnosisZixuan Hu, Hui Ming Lin, Shobhit Mathur, et al.
The Prostate|July 31, 2016
Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate CancerHannah M Bruce, Phillip D Stricker, Ruta Gupta, et al.
Journal of Proteome Research|February 10, 2010
Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's diseaseHui-Ming Lin, Matthew P G Barnett, Nicole C Roy, et al.
British Journal of Cancer|March 10, 2017
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancerHui-Ming Lin, Kate L Mahon, Calan Spielman, et al.
Oncotarget|August 5, 2016
A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excisionXiao-Jie Wang, Pan Chi, Hui-Ming Lin, et al.
Therapeutic Advances in Medical Oncology|December 18, 2024
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapyRhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Pageof 8